Validation of these results through prospective or interventional studies could enable earlier identification of diabetic patients at increased risk of renal dysfunction, particularly among those displaying concurrent abnormalities in lipid and GPR-120 profiles. Here, FFAR4 is linked to Abnormal renal physiology.